Hyland/Travenol learned of Behringwerke's product which was treated to eliminate the risk of hepatitis. Linked evidence CGRA0000218 - Memo from Robert Taub to H Terreer and others - 02 Feb 1979 Chronology Information Date: 2 February 1979 Chapter/issue Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates